sulfasalazine has been researched along with Abnormalities, Autosome in 4 studies
Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Navarro, JT | 1 |
| Ribera, JM | 1 |
| Mate, JL | 1 |
| Granada, I | 1 |
| Juncà, J | 1 |
| Batlle, M | 1 |
| Millá, F | 1 |
| Feliu, E | 1 |
| Mitelman, F | 2 |
| Strömbeck, B | 2 |
| Ursing, B | 2 |
| Nordle, O | 1 |
| Hartley-Asp, B | 1 |
| Bishop, JB | 1 |
| Witt, KL | 1 |
| Gulati, DK | 1 |
| MacGregor, JT | 1 |
2 trials available for sulfasalazine and Abnormalities, Autosome
| Article | Year |
|---|---|
No cytogenic effect of metronidazole.
Topics: Chromosome Aberrations; Clinical Trials as Topic; Crohn Disease; Humans; Metronidazole; Random Alloc | 1980 |
Metronidazole exhibits no clastogenic activity in a double-blind cross-over study on Crohn's patients.
Topics: Adolescent; Adult; Chromosome Aberrations; Chromosomes; Crohn Disease; Female; Humans; Male; Metroni | 1982 |
2 other studies available for sulfasalazine and Abnormalities, Autosome
| Article | Year |
|---|---|
Hepatosplenic T-gammadelta lymphoma in a patient with Crohn's disease treated with azathioprine.
Topics: Adrenal Cortex Hormones; Adult; Antineoplastic Combined Chemotherapy Protocols; Autoimmune Diseases; | 2003 |
Evaluation of the mutagenicity of the anti-inflammatory drug salicylazosulfapyridine (SASP).
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Bone Marrow; Cell Line; Chromosome Aberrations; Erythrocy | 1990 |